Cargando…
Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination
BACKGROUND/PURPOSE: Vogt-Koyanagi-Harada (VKH) disease is a primary stromal choroiditis with bilateral granulomatous panuveitis. If initial-onset VKH is treated early and relentlessly the disease can be controlled and even “cured” in a substantial number of cases. We are reporting on a patient treat...
Autores principales: | Papasavvas, Ioannis, Herbort, Carl P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256412/ https://www.ncbi.nlm.nih.gov/pubmed/34224024 http://dx.doi.org/10.1186/s12348-021-00251-5 |
Ejemplares similares
-
Vogt-Koyanagi-Harada disease is always bilateral: reports of unilateral cases failed to use choroidal investigations showing subclinical involvement of the fellow eye
por: Papasavvas, Ioannis, et al.
Publicado: (2021) -
Vogt–Koyanagi–Harada is a Curable Autoimmune Disease: Early Diagnosis and Immediate Dual Steroidal and Non-Steroidal Immunosuppression are Crucial Prerequisites
por: Papasavvas, Ioannis, et al.
Publicado: (2020) -
Rituximab in refractory Vogt–Koyanagi–Harada disease
por: Dolz-Marco, Rosa, et al.
Publicado: (2011) -
Indocyanine Green Angiography Guided Management of Vogt-Koyanagi-Harada Disease
por: Bouchenaki, Nadia, et al.
Publicado: (2011) -
Reversible alopecia in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia
por: Chuang, Chiu-Tung, et al.
Publicado: (2013)